Expert Opinion on Investigational Drugs, Volume 29, Issue 8 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 29, Issue 8 (2020)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Volume 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Drug Evaluation

Article
Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential
Julia Brandts & Kausik K. Ray
Pages: 763-770
Published online: 21 Jun 2020
AbstractforBempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential | Full Text | References | PDF (491.7 KB) | EPUB
  • 554 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
Giacomo Sgalla, Claudia Franciosa, Jacopo Simonetti & Luca Richeldi
Pages: 771-777
Published online: 07 Jun 2020
AbstractforPamrevlumab for the treatment of idiopathic pulmonary fibrosis | Full Text | References | PDF (1.2 MB) | EPUB
  • 1710 Views
  • 28 CrossRef citations
  • 0Altmetric
Article
Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer
Giulio Evangelisti, Fabio Barra, Melita Moioli, Paolo Sala, Sara Stigliani, Claudio Gustavino, Sergio Costantini & Simone Ferrero
Pages: 779-792
Published online: 25 Jun 2020
AbstractforPrexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer | Full Text | References | PDF (1.9 MB) | EPUB
  • 362 Views
  • 6 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Does lopinavir measure up in the treatment of COVID-19?
Sheila A. Doggrell
Pages: 793-796
Published online: 12 Jun 2020
AbstractforDoes lopinavir measure up in the treatment of COVID-19? | Full Text | References | PDF (194.2 KB) | EPUB
  • 1942 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

Shedding light on developmental drugs for idiopathic pulmonary fibrosis
Paolo Spagnolo, Francesco Bonella, Christopher J Ryerson, Argyris Tzouvelekis & Toby M Maher
Pages: 797-808
Published online: 24 Jun 2020
AbstractforShedding light on developmental drugs for idiopathic pulmonary fibrosis | Full Text | References | PDF (402.2 KB) | EPUB
  • 718 Views
  • 8 CrossRef citations
  • 0Altmetric
Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials
Leslie Padrnos & Ruben Mesa
Pages: 809-817
Published online: 16 Jul 2020
AbstractforNovel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials | Full Text | References | PDF (330.7 KB) | EPUB
  • 176 Views
  • 2 CrossRef citations
  • 0Altmetric
Current and experimental drug therapy for the treatment of polycystic ovarian syndrome
Luigi Della Corte, Virginia Foreste, Fabio Barra, Claudio Gustavino, Franco Alessandri, Maria Grazia Centurioni, Simone Ferrero, Giuseppe Bifulco & Pierluigi Giampaolino
Pages: 819-830
Published online: 27 Jun 2020
AbstractforCurrent and experimental drug therapy for the treatment of polycystic ovarian syndrome | Full Text | References | PDF (402 KB) | EPUB
  • 690 Views
  • 23 CrossRef citations
  • 0Altmetric
Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
Ernane Souza, Katherine H. Cho, Shelby T. Harris, Naomi R. Flindt, Richard K. Watt & Amy Barton Pai
Pages: 831-844
Published online: 16 Jun 2020
AbstractforHypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease? | Full Text | References | PDF (1.2 MB) | EPUB
  • 908 Views
  • 7 CrossRef citations
  • 0Altmetric
Therapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy
Rossella Talotta, Fabiola Atzeni & Magdalena Janina Laska
Pages: 845-867
Published online: 07 Jul 2020
AbstractforTherapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy | Full Text | References | PDF (3.3 MB) | EPUB
  • 310 Views
  • 2 CrossRef citations
  • 0Altmetric
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
Fortunato Morabito, Massimo Gentile, Paola Monti, Anna Grazia Recchia, Paola Menichini, Mamdouh Skafi, Moien Atrash, Giuseppa De Luca, Sabrina Bossio, Hamdi Al-Janazreh, Sara Galimberti, Zaidoun Salah, Lucio Morabito, Alham Mujahed, Musa Hindiyeh, Mariella Dono, Franco Fais, Giovanna Cutrona, Antonino Neri, Giovanni Tripepi, Gilberto Fronza & Manlio Ferrarini
Pages: 869-880
Published online: 27 Jun 2020
AbstractforTP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors | Full Text | References | PDF (2 MB) | EPUB
  • 293 Views
  • 10 CrossRef citations
  • 0Altmetric
Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials
Guilherme Wesley Peixoto Da Fonseca, Elke Dworatzek, Nicole Ebner & Stephan Von Haehling
Pages: 881-891
Published online: 18 Jun 2020
AbstractforSelective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials | Full Text | References | PDF (2.6 MB) | EPUB
  • 1146 Views
  • 25 CrossRef citations
  • 0Altmetric

Explore articles